COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - share repurchase programme
16/02/2026
Bagsværd, Denmark, 16 February 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
16/02/2026
Jennings-Brown will drive AI and technology strategy and lead the development of capabilities enabling discovery of therapeutics targeting fundamental aging mechanisms Offices in Abu Dhabi's premier biotechnology hub to [...]
LEX Diagnostics Receives FDA 510(k) Clearance and CLIA Waiver for LEX VELO System
16/02/2026
Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutes CAMBRIDGE, United Kingdom, Feb. 16, 2026 (GLOBE NEWSWIRE) -- LEX Diagnostics, a leading [...]
Communiqué de presse : L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS
16/02/2026
L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS La première étude montre que les nourrissons vaccinés contre le [...]
GN Store Nord A/S - Notice to convene the Annual General Meeting 2026
16/02/2026
GN Store Nord’s Annual General Meeting will be held on Wednesday, March 11, 2026, at 10:00 a.m. CET at the company’s address: Lautrupbjerg 7, 2750 Ballerup, Denmark. Please find attached the notice to convene the Annual [...]
Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board
16/02/2026
HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated target in Huntington’s disease Clinical Advisory Board formed to support progression [...]
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
16/02/2026
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV hospitalizations [...]
Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470
16/02/2026
Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 U.S. NDA submission on track for summer 2026 Nicox to receive milestone payment from Kowa upon submission of the NDA NDA [...]
Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470
16/02/2026
Communiqué de presse Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470 Le dépôt de la demande d’autorisation de mise sur le marché (NDA) aux Etats-Unis reste prévu pour l’été 2026 Nicox [...]
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
16/02/2026
MAJESTY, the first global phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years Up to 30% of people with membranous nephropathy progress to kidney failure over 10 [...]
Sapu Bioscience Expands International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
15/02/2026
SAN DIEGO, CA, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Sapu Bioscience today announced advancements in its global IP portfolio supporting OT-101 , its proprietary TGF-β antisense therapeutic platform, strengthening protection [...]
SCIENTIFICALLY UNREFUTED: A Breakthrough Invention Saving Millions of Lives and Billions of Dollars Awaits a Public Comparative Evaluation Within CPRIT’s $6 Billion Cancer Program
15/02/2026
Crosetto’s technology was recognized as a breakthrough invention by FERMILAB and awarded a $1 million U.S. DOE grant; these achievements, along with other inventions, earned the inventor a U.S. Green Card for ‘ [...]
BioRestorative Announces Closing of $5.0 Million Public Offering
14/02/2026
MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage clinical regenerative medicine innovator focused on stem cell- [...]
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
13/02/2026
FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong mechanistic and biological plausibility supporting the use of the PPIX biomarker [...]
SRX Health Solutions Inc. Announces Fiscal First Quarter 2026 Results for Quarter Ended December 31, 2025
13/02/2026
Executed Definitive Agreement to Acquire EMJ Crypto Technologies ("EMJX"), a “Gen 2” Digital-Asset Treasury Platform, Anticipated to Close in first half of Calendar 2026 Strengthened Balance Sheet, with $13.1 Million in [...]
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2026
NEW HOPE, Pa., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through [...]
Paretofit Launches Digital Health Coaching System for Entrepreneurs in Europe’s DACH Region
13/02/2026
Built on a proven 98.1% success rate, the evidence-based 80/20 approach is now available online – tailored for self-employed professionals and entrepreneurs in Germany, Austria, and Switzerland. Cologne, Germany, Feb. [...]
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
13/02/2026
CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
4DMT Announces New Employment Inducement Grants
13/02/2026
EMERYVILLE, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]

Pages